Pfizer and its German partner today filed a counter claim against Moderna's patent-infringement suit over Covid-19 vaccines, saying that not only didn't they use Moderna's patented technology to develop their own Covid-19 vaccine, they're not a bunch of greedy money-grubbers seeking to re-write the history of mRNA technology - which they say started long before Moderna even existed. Read more.
- 2 comments
Covid-19 vaccine maker Moderna, founded in Cambridge in 2010, this morning sued Pfizer, which has research facilities here, for patent infringement, alleging Pfizer and its German partner copied its patented mRNA technology to make their competing vaccine. Read more.
Pfizer, Covid-19 vaccine partner sue maker of failed vaccine to keep it from claiming they stole from its patents
Pfizer, which has research and vaccine manufacturing facilities in Cambridge and Andover, and BioNTech, a German drug company with an office in Cambridge, are asking a federal judge to declare the recipe for their Covid-19 vaccine doesn't infringe on any patents held by CureVac, a German company with an office on Fort Point Channel that tried and failed to develop a marketable Covid-19 vaccine. Read more.
The pharmaceutical giant Pfizer is looking to consolidate its two Cambridge locations into a single, more centrally-located facility. FierceBiotech reports. The company said in a release that it plans to "enhance its presence" in Cambridge, and to shift "selected resources" up from Groton. That, presumably, translates to more high-caliber biotech jobs for the Boston area.